Patents by Inventor Anne Luong

Anne Luong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240122910
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Application
    Filed: May 17, 2023
    Publication date: April 18, 2024
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Patent number: 11690836
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Grant
    Filed: June 15, 2021
    Date of Patent: July 4, 2023
    Assignee: AKEBIA THERAPEUTICS, INC.
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Publication number: 20220040159
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Application
    Filed: June 15, 2021
    Publication date: February 10, 2022
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Patent number: 11065237
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Grant
    Filed: February 10, 2020
    Date of Patent: July 20, 2021
    Assignee: Akebia Therapeutics, Inc.
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Publication number: 20200345711
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Application
    Filed: February 10, 2020
    Publication date: November 5, 2020
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Patent number: 10596158
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: March 24, 2020
    Assignee: Akebia Therapeutics, Inc.
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Publication number: 20190290624
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Application
    Filed: November 1, 2018
    Publication date: September 26, 2019
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Patent number: 10150734
    Abstract: Provided herein are solid forms comprising 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, methods of making the solid forms, methods of their use for the treatment of various diseases and/or disorders and pharmaceutical compositions comprising the solid forms.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: December 11, 2018
    Assignee: Akebia Therapeutics, Inc.
    Inventors: Roger Hanselmann, Anne Luong
  • Patent number: 10149842
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: December 11, 2018
    Assignee: Akebia Therapeutics, Inc.
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Publication number: 20180280365
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Application
    Filed: May 31, 2018
    Publication date: October 4, 2018
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Patent number: 9987262
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: June 5, 2018
    Assignee: Akebia Therapeutics, Inc.
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Publication number: 20170258773
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 14, 2017
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Patent number: 9701636
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: July 11, 2017
    Assignee: Akebia Therapeutics, Inc.
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Publication number: 20160214939
    Abstract: Provided herein are solid forms comprising 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, methods of making the solid forms, methods of their use for the treatment of various diseases and/or disorders and pharmaceutical compositions comprising the solid forms.
    Type: Application
    Filed: January 22, 2016
    Publication date: July 28, 2016
    Inventors: ROGER HANSELMANN, ANNE LUONG
  • Publication number: 20150141467
    Abstract: Provided herein are solid forms comprising {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders.
    Type: Application
    Filed: November 14, 2014
    Publication date: May 21, 2015
    Inventors: James Densmore Copp, Ann W. Newman, Anne Luong
  • Publication number: 20140187771
    Abstract: The invention provides an amorphous solid of a compound of formula (I) or of a salt thereof as well as compositions comprising the amorphous solids, and methods for making and using the amorphous solids.
    Type: Application
    Filed: April 30, 2012
    Publication date: July 3, 2014
    Applicant: Gilead Sciences, Inc.
    Inventors: Joanna M. Koziara, Anne Luong, Keiko Sujino, Richard Yu